Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Anika Therapeutics Inc. (ANIK) had Return on Equity of 1.26% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$30.61M |
|
$0.29M |
|
$11.44M |
|
$19.18M |
|
$29.97M |
|
$0.65M |
|
$0.12M |
|
$0.76M |
|
$0.76M |
|
$1.80M |
|
$1.80M |
|
$0.29M |
|
$1.80M |
|
$0.65M |
|
$1.96M |
|
14.34M |
|
14.34M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$103.36M |
|
$40.32M |
|
$86.91M |
|
$190.27M |
|
$21.91M |
|
-- |
|
$24.90M |
|
$46.80M |
|
$143.47M |
|
$133.76M |
|
$143.47M |
|
13.89M |
|
| Cash Flow Statement Financials | |
$11.19M |
|
$-0.40M |
|
$-10.55M |
|
$57.16M |
|
$57.48M |
|
$0.32M |
|
$10.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.65% |
|
2.11% |
|
2.11% |
|
-- |
|
2.50% |
|
0.95% |
|
$4.96M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.61 |
|
1.29 |
|
69.64 |
|
|
Return on Equity |
1.26% |
1.35% |
|
0.95% |
|
1.26% |
|
$10.33 |
|
$0.35 |
|
$0.78 |
|